chevron_leftBack
As of 5 June 2026, Shanghai Pharmaceuticals Holding Co., Ltd. has a market cap of $8.36B USD, ranking #2566 globally and #427 in China.
It ranks #190 in the Healthcare sector, and #70 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$8.36BUSD
56.61B CNY
Enterprise Value
$12.5BUSD
84.64B CNY
Revenue (TTM)
$42.56BUSD
288.08B CNY
EBITDA (TTM)
$1.61BUSD
10.89B CNY
Net Income (TTM)
$858.15MUSD
5.81B CNY
EBITDA Margin
3.8%
Profit Margin
2%
PE Ratio
10.8
Forward PE
12.3
PS Ratio
0.2
PB Ratio
0.6
EV/EBITDA
7.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bo Shen
open_in_new
Employees
49,608
Founded
1994
Website
sphchina.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1% | 0.7% | 2.4% | -1.9% | -6.6% | -4.9% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
601607
上海医药集团股份有限公司 Class A
ISIN: CNE000000C82
Shares Out.:
Shares Outstanding:
2.789B1
Shares Float:
676.715M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
17.09 CNY | |
|
2607
上海医药集团股份有限公司 Class H
ISIN: CNE1000012B3
Shares Out.:
Shares Outstanding:
919.073M1
Shares Float:
578.115M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
11.76 HKD | |
|
S1R
上海医药集团股份有限公司 Class H
ISIN: CNE1000012B3
Shares Out.:
Shares Outstanding:
919.073M1
Shares Float:
615.525M2
|
1.22 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.9B
545%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.69B
494%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
241%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
125%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.53B
98%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
91%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
9K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
6K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
4K%
|
97.4
|
|
SIX: RO
|
$324.68B
4K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
3K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
3K%
218.9B CHF
|
20.5
|
chevron_leftBack